Videos

At a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, members discussed the safety of drugs called “COX-2” inhibitors, such as Vioxx and Celebrex. Dr. …

The Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees continued discussions in their joint meeting on possible safety of risks of “COX-2” inhib…

Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and for the Food and Drug Administration spoke about a number of issues in…

Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drugs Celebrex, Bextra, Parecoxib, and Naproxen spoke as did representatives for the Fo…

A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the …

Health care officials, pharmaceutical industry representatives, and members of the public commented on proposals by the Food and Drug Administration to approve several prescription allergy d…